On July 17, 2026, the company received notice from Nasdaq that it failed to maintain the minimum $1.00 bid price under Listing Rule 5550(a)(2) after 30 consecutive business days below the threshold. InspireMD has 180 days, until January 13, 2027, to regain compliance, and its stock continues to trade on Nasdaq under the symbol NSPR.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.